General Information of DTT (ID: TTS5K1M)

DTT Name Hepatitis B virus Reverse transcriptase (HBV RT) DTT Info
Gene Name HBV RT

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
2 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Adefovir Dipivoxil DMMAWY1 Hepatitis B virus infection 1E51.0 Approved [1]
Entecavir DM7VTQO Hepatitis B virus infection 1E51.0 Approved [2]
------------------------------------------------------------------------------------
4 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clevudine DMR21Q3 Hepatitis B 1E51 Phase 3 [3]
LB80380 DMJM9LZ Hepatitis B virus infection 1E51.0 Phase 2b [4]
MIV-210 DM2NF6X Hepatitis B virus infection 1E51.0 Phase 2 [5]
Pradefovir DM1O0DV Hepatitis virus infection 1E50-1E51 Phase 2 [6]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
2 Effect of hepatitis B virus reverse transcriptase variations on entecavir treatment response. J Infect Dis. 2014 Sep 1;210(5):701-7.
3 2011 Pipeline of Bukwang.
4 2011 Pipeline of LG Life Sciences.
5 Emerging antivirals for the treatment of hepatitis B
6 DOI: 10.1128/AAC.01566-05